Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Nakamoto Inc.NASDAQ: NAKA

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $7.58M rose 649.7% year over year, ahead of the +353.9% change in trailing-twelve-month cost of revenue. Sequentially, it fell 31.5% from the prior quarter. Over 3 fiscal years it compounded at +317.5% a year.

Context

  • Cost of revenue amounted to 608.8% of revenue in FY2025, up 477.8 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +649.7% holds above the trailing-twelve-month pace of +353.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.58M-31.5% QoQ
Last fiscal yearDec 2025
$11.09M+211.3% YoY
LTMMar 2026
$18.66M+353.9% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+649.7%——
1 year+211.3%——
3-year CAGR+317.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
11.09M USD
Year-over-year change
+211.3%
4-year CAGR
+62.5%

Cost of Revenue vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 cost of revenue of $18.66M is the 6th highest of the 11 companies compared; the peer median is $19.84M.
  • Its year-over-year change of +353.9% is the highest of 9, against a peer median of +19.3%.
  • Cost of revenue amounts to 476.0% of revenue for NAKA, versus a peer median of 35.4%.
NAKA Competitors Peer median
Cost of Revenue for NAKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$5.98B -0.5%+39.0%102.7%
AMRNAmarin Corporation plcLTM Mar 2026$102.11M -27.2%-9.9%47.5%
DHDefinitive Healthcare Corp.LTM Mar 2026$65.42M +14.6%+11.0%27.5%
SLPSimulations Plus, Inc.LTM Feb 2026$30.63M -12.8%+44.9%38.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$26.56M +23.9%+21.8%32.7%
NAKANakamoto Inc.LTM Mar 2026$18.66M +353.9%+317.5%476.0%
DBVTDBV Technologies S.A.LTM Mar 2026$13.12M +215.9%-4.5%—
DCTHDelcath Systems, Inc.LTM Mar 2026$12.69M +56.1%+158.1%14.0%
CLLSCellectis S.A.LTM Mar 2026$12.33M +39.3%+4.9%18.1%
LYELLyell Immunopharma, Inc.LTM Mar 2026$2.33M ——7522.6%
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$0 ———
Peer median (excluding NAKA) $19.84M+19.3%+16.4%35.4%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.5M3.79M3.77M2.72M1.82M
Cost of Revenue1.59M152.39K226.17K3.56M11.09M
Gross Profit914.92K3.63M3.54M(842.57K)(9.27M)
Gross Margin36.5%96.0%94.0%-31.0%-508.8%
Research & Development002.5K377.73K0
Selling, General & Admin853.58K6.27M5.05M1.91M11.76M
Operating Expenses853.58K6.33M5.16M2.5M187.87M
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
EBITDA124.74K(2.42M)(1.36M)(3M)(44.93M)
EBITDA Margin5.0%-63.9%-36.0%-110.4%-2466.7%
Operating Income61.34K(2.69M)(1.62M)(3.35M)(197.14M)
Operating Margin2.4%-71.1%-43.0%-123.1%-10824.0%
Interest Income00000
Interest Expense0055.84K393.45K7.06M
Other Income / Expenses88K152.82K2.76K(270.88K)144.91M
Income Before Tax149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Pre-Tax Margin6.0%-67.1%-42.9%-133.0%-2867.6%
Income Tax Expense00000
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Net Margin6.0%-67.1%-42.9%-133.0%-2867.6%
EPS (Basic)0.03(0.43)(0.27)(0.67)(10.40)
EPS (Diluted)0.03(0.43)(0.27)(0.67)(10.40)
Weighted Avg Shares5.97M5.89M5.89M5.39M11.36M
Weighted Avg Shares (Diluted)5.97M5.89M5.89M5.39M11.36M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.